Vivo Capital, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$207.3 - $300.31 $12.9 Million - $18.7 Million	-62,220 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$101.55 - $313.9 $3.55 Million - $11 Million	35,000 Added 128.58%	62,220 $17.4 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $2.54 Million - $4.06 Million	27,220 New	27,220 $3.18 Million

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.35B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.